Ulotaront (INNTooltip International Nonproprietary Name; developmental codes SEP-363856, SEP-856) is an investigational antipsychotic that is undergoing...
10 KB (815 words) - 14:07, 11 January 2024
3-MMA Norfenfluramine Phentermine o-PIT Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RO5166017 N,N-Dimethylphenethylamine Ulotaront (SEP-363856)...
42 KB (4,237 words) - 11:16, 16 May 2024
mechanisms, ligands, and physiological functions of these receptors. Ulotaront / SEP 363856 is a TAAR1 agonist in phase 3 clinical trials for schizophrenia...
32 KB (2,036 words) - 11:13, 25 February 2024
to form Sumitomo Pharma America, Inc. (SMPA), effective July 1, 2023. Ulotaront (SEP-856) – phase III Aramisulpride:esamisulpride (85:15 ratio) (SEP-4199)...
7 KB (637 words) - 11:56, 24 August 2023
3-MMA Norfenfluramine Phentermine o-PIT Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RO5166017 N,N-Dimethylphenethylamine Ulotaront (SEP-363856)...
19 KB (2,166 words) - 18:35, 24 August 2023
Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, et al. (January 2022). "Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia". ACS Medicinal Chemistry...
37 KB (3,892 words) - 21:58, 26 March 2024
promoting and cognition enhancing properties in murine and simian models. Ulotaront, investigational antipsychotic. Guanfacine, ADHD medication. Ralmitaront...
56 KB (6,646 words) - 14:10, 16 January 2024
3-MMA Norfenfluramine Phentermine o-PIT Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RO5166017 N,N-Dimethylphenethylamine Ulotaront (SEP-363856)...
14 KB (1,633 words) - 12:53, 14 April 2023
version of amisulpride) Ralmitaront (RG-7906, RO-6889450) – TAAR1 agonist Ulotaront (SEP-856, SEP-363856) – 5-HT1A receptor and TAAR1 agonist Usmarapride...
10 KB (752 words) - 23:51, 10 December 2023
3-MMA Norfenfluramine Phentermine o-PIT Propylhexedrine Ralmitaront (RG-7906, RO-6889450) RO5166017 N,N-Dimethylphenethylamine Ulotaront (SEP-363856)...
8 KB (949 words) - 16:22, 16 August 2023